PhaseRx - Dividend History | PZRXQ

Historical dividend payout and yield for PhaseRx (PZRXQ) since 1971. The current TTM dividend payout for PhaseRx (PZRXQ) as of December 31, 1969 is $0.00. The current dividend yield for PhaseRx as of December 31, 1969 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.000B
PhaseRx, Inc. is a preclinical biopharmaceutical company. It is engaged in developing products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The Company's i-ERT approach is enabled by its proprietary Hybrid mRNA Technology(TM) platform. PhaseRx, Inc. is headquartered in Seattle, Wash.
Stock Name Country Market Cap PE Ratio